{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "20", "@year": "2020", "@timestamp": "2020-01-20T04:10:47.000047-05:00", "@month": "01"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "09"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "@afid": "60005255", "@country": "tha", "organization": [{"$": "Department of Obstetrics and Gynecology"}, {"$": "Rajavithi Hospital"}], "affiliation-id": {"@afid": "60005255", "@dptid": "113200468"}, "@dptid": "113200468"}, "author": [{"ce:given-name": "Marut", "preferred-name": {"ce:given-name": "Marut", "ce:initials": "M.", "ce:surname": "Yanaranop", "ce:indexed-name": "Yanaranop M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Yanaranop", "@auid": "6504113309", "ce:indexed-name": "Yanaranop M."}]}, {"affiliation": {"country": "Thailand", "@afid": "60023366", "@country": "tha", "organization": [{"$": "College of Medicine"}, {"$": "Rangsit University"}], "affiliation-id": {"@afid": "60023366", "@dptid": "106001925"}, "@dptid": "106001925"}, "author": [{"ce:given-name": "Marut", "preferred-name": {"ce:given-name": "Marut", "ce:initials": "M.", "ce:surname": "Yanaranop", "ce:indexed-name": "Yanaranop M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Yanaranop", "@auid": "6504113309", "ce:indexed-name": "Yanaranop M."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Obstetrics and Gynecology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113356767"}, "@dptid": "113356767"}, "author": [{"ce:given-name": "Surasith", "preferred-name": {"ce:given-name": "Surasith", "ce:initials": "S.", "ce:surname": "Chaithongwongwatthana", "ce:indexed-name": "Chaithongwongwatthana S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Chaithongwongwatthana", "@auid": "6602320037", "ce:indexed-name": "Chaithongwongwatthana S."}]}], "citation-title": "Intravenous versus oral dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in patients with primary ovarian, fallopian tube and peritoneal cancer: A double-blind randomized controlled trial", "abstracts": "\u00a9 2016 John Wiley & Sons Australia, LtdAim: To compare the efficacies and side effects of intravenous and oral dexamethasone (IV-D and PO-D) for paclitaxel-associated hypersensitivity reaction (P-HSR) prophylaxis in patients with primary ovarian, fallopian tube and peritoneal carcinomas (POC/PFTC/PPC) receiving a first cycle of paclitaxel plus carboplatin (TC). Methods: In this double-blind randomized controlled trial, patients with POC/PFTC/PPC receiving a first cycle of TC were randomly allocated in a 1:1 ratio to either the IV-D or PO-D groups. Those were followed at 28 days. Primary outcomes were incidence of overall and severe P-HSRs. Secondary outcomes included incidence of dexamethasone-related side effects, other chemotherapy-related adverse events (AEs), and quality-of-life (QoL). Results: A total of 288 patients were enrolled from February to July 2015, of whom 281 were eligible for analysis, including 140 allocated to IV-D and 141 to PO-D. There was no significant difference in P-HSR rate between the IV-D and PO-D groups (17.9% vs. 19.1%, P = 0.780). Severe P-HSR occurred in one women in the IV-D group (0.7% vs. 0%, P = 0.498). There were no significant differences in other chemotherapy-related AEs and QoL scores. However, women in the PO-D had more side effects from short-term corticosteroid use than those in the IV-D group, especially acne (10.6% vs. 2.1%, P = 0.004). Conclusions: IV-D and PO-D have similar efficacies for preventing P-HSR. However, short-term IV-D may be associated with fewer side effects than PO-D. IV-D is thus suggested for P-HSR prophylaxis in patients with POC/PFTC/PPC receiving a first cycle of TC.", "correspondence": {"affiliation": {"country": "Thailand", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Obstetrics and Gynecology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Surasith", "ce:initials": "S.", "ce:surname": "Chaithongwongwatthana", "ce:indexed-name": "Chaithongwongwatthana S."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "dexamethasone", "@xml:lang": "eng"}, {"$": "hypersensitivity reaction", "@xml:lang": "eng"}, {"$": "ovarian cancer", "@xml:lang": "eng"}, {"$": "paclitaxel", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"sourcetitle-abbrev": "Asia-Pac. J. Clin. Oncol.", "website": {"ce:e-address": {"$": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1743-7563", "@type": "email"}}, "@country": "gbr", "translated-sourcetitle": {"$": "Asia-Pacific Journal of Clinical Oncology", "@xml:lang": "eng"}, "issn": [{"$": "17437563", "@type": "electronic"}, {"$": "17437555", "@type": "print"}], "volisspag": {"voliss": {"@volume": "12", "@issue": "3"}, "pagerange": {"@first": "289", "@last": "299"}}, "@type": "j", "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Blackwell Publishing Ltd", "ce:e-address": {"$": "customerservices@oxonblackwellpublishing.com", "@type": "email"}}, "sourcetitle": "Asia-Pacific Journal of Clinical Oncology", "@srcid": "4000148021", "publicationdate": {"month": "09", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 September 2016"}, "day": "01"}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "10", "classification-description": "Obstetrics and Gynecology"}, {"classification-code": "16", "classification-description": "Cancer"}, {"classification-code": "26", "classification-description": "Immunology, Serology and Transplantation"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}]}, {"@type": "ASJC", "classification": "2730"}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": {"@source": "esbd", "chemical": [{"cas-registry-number": "41575-94-4", "chemical-name": "carboplatin"}, {"cas-registry-number": "50-02-2", "chemical-name": "dexamethasone"}, {"cas-registry-number": "103882-84-4", "chemical-name": "gemcitabine"}, {"cas-registry-number": "33069-62-4", "chemical-name": "paclitaxel"}]}}}}, "item-info": {"copyright": {"$": "Copyright 2018 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "MEDL"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "12", "@year": "2018", "@timestamp": "BST 15:20:32", "@month": "03"}}, "itemidlist": {"itemid": [{"$": "611830357", "@idtype": "PUI"}, {"$": "610073482", "@idtype": "associatedPUI"}, {"$": "654340587", "@idtype": "CAR-ID"}, {"$": "20160618204", "@idtype": "EMBASE"}, {"$": "27098551", "@idtype": "MEDL"}, {"$": "2016295707", "@idtype": "NURSNG"}, {"$": "20161807864", "@idtype": "REAXYSCAR"}, {"$": "20180722187", "@idtype": "SCOPUS"}, {"$": "84983311786", "@idtype": "SCP"}, {"$": "84983311786", "@idtype": "SGR"}], "ce:doi": "10.1111/ajco.12495"}}, "tail": {"bibliography": {"@refcount": "23", "reference": [{"ref-fulltext": "Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: CA Cancer J Clin 2015; 65: 87\u2013108.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Global cancer statistics, 2012"}, "refd-itemidlist": {"itemid": {"$": "84924271853", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "65"}, "pagerange": {"@first": "87", "@last": "108"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.A.", "@_fa": "true", "ce:surname": "Torre", "ce:indexed-name": "Torre L.A."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Bray", "ce:indexed-name": "Bray F."}, {"@seq": "3", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Siegel", "ce:indexed-name": "Siegel R.L."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ferlay", "ce:indexed-name": "Ferlay J."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lortet-Tieulent", "ce:indexed-name": "Lortet-Tieulent J."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Jemal", "ce:indexed-name": "Jemal A."}]}, "ref-sourcetitle": "CA: CA Cancer J Clin"}}, {"ref-fulltext": "du Bois A, Quinn M, Thigpen T et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 2005; 16 (Suppl 8): viii7\u201312.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)"}, "refd-itemidlist": {"itemid": {"$": "27744551640", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "7", "@last": "12"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "du Bois", "ce:indexed-name": "du Bois A."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Quinn", "ce:indexed-name": "Quinn M."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Thigpen", "ce:indexed-name": "Thigpen T."}], "et-al": null}, "ref-sourcetitle": "Ann Oncol"}}, {"ref-fulltext": "Weiss RB, Donehower RC, Wiernik PH et al. Hypersensitivity reactions from taxol. J Clin Oncol 1990; 8: 1263\u20138.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "1990"}, "ref-title": {"ref-titletext": "Hypersensitivity reactions from taxol"}, "refd-itemidlist": {"itemid": {"$": "0025326680", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "1263", "@last": "1268"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.B.", "@_fa": "true", "ce:surname": "Weiss", "ce:indexed-name": "Weiss R.B."}, {"@seq": "2", "ce:initials": "R.C.", "@_fa": "true", "ce:surname": "Donehower", "ce:indexed-name": "Donehower R.C."}, {"@seq": "3", "ce:initials": "P.H.", "@_fa": "true", "ce:surname": "Wiernik", "ce:indexed-name": "Wiernik P.H."}], "et-al": null}, "ref-sourcetitle": "J Clin Oncol"}}, {"ref-fulltext": "Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med 1995; 332: 1004\u201314.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "1995"}, "ref-title": {"ref-titletext": "Paclitaxel (taxol)"}, "refd-itemidlist": {"itemid": {"$": "84994521433", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "332"}, "pagerange": {"@first": "1004", "@last": "1014"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.K.", "@_fa": "true", "ce:surname": "Rowinsky", "ce:indexed-name": "Rowinsky E.K."}, {"@seq": "2", "ce:initials": "R.C.", "@_fa": "true", "ce:surname": "Donehower", "ce:indexed-name": "Donehower R.C."}]}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Szebeni J. Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity. Toxicology 2005; 216: 106\u201321.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity"}, "refd-itemidlist": {"itemid": {"$": "28244466864", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "216"}, "pagerange": {"@first": "106", "@last": "121"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Szebeni", "ce:indexed-name": "Szebeni J."}]}, "ref-sourcetitle": "Toxicology"}}, {"ref-fulltext": "Kintzel PE. Prophylaxis for paclitaxel hypersensitivity reactions. Ann Pharmacother 2001; 35: 1114\u20137.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Prophylaxis for paclitaxel hypersensitivity reactions"}, "refd-itemidlist": {"itemid": {"$": "0034823672", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "35"}, "pagerange": {"@first": "1114", "@last": "1117"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.E.", "@_fa": "true", "ce:surname": "Kintzel", "ce:indexed-name": "Kintzel P.E."}]}, "ref-sourcetitle": "Ann Pharmacother"}}, {"ref-fulltext": "Sendo T, Sakai N, Itoh Y et al. Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy. Cancer Chemother Pharmacol 2005; 56: 91\u20136.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy"}, "refd-itemidlist": {"itemid": {"$": "21244467059", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "91", "@last": "96"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Sendo", "ce:indexed-name": "Sendo T."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Sakai", "ce:indexed-name": "Sakai N."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Itoh", "ce:indexed-name": "Itoh Y."}], "et-al": null}, "ref-sourcetitle": "Cancer Chemother Pharmacol"}}, {"ref-fulltext": "Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E. Phase I clinical and pharmacokinetic study of taxol. Cancer Res 1987; 47: 2486\u201393.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "1987"}, "ref-title": {"ref-titletext": "Phase I clinical and pharmacokinetic study of taxol"}, "refd-itemidlist": {"itemid": {"$": "0023261546", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "47"}, "pagerange": {"@first": "2486", "@last": "2493"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.H.", "@_fa": "true", "ce:surname": "Wiernik", "ce:indexed-name": "Wiernik P.H."}, {"@seq": "2", "ce:initials": "E.L.", "@_fa": "true", "ce:surname": "Schwartz", "ce:indexed-name": "Schwartz E.L."}, {"@seq": "3", "ce:initials": "J.J.", "@_fa": "true", "ce:surname": "Strauman", "ce:indexed-name": "Strauman J.J."}, {"@seq": "4", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Dutcher", "ce:indexed-name": "Dutcher J.P."}, {"@seq": "5", "ce:initials": "R.B.", "@_fa": "true", "ce:surname": "Lipton", "ce:indexed-name": "Lipton R.B."}, {"@seq": "6", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Paietta", "ce:indexed-name": "Paietta E."}]}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "Bookman MA, Kloth DD, Kover PE, Smolinski S, Ozols RF. Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions. Ann Oncol 1997; 8: 611\u20134.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions"}, "refd-itemidlist": {"itemid": {"$": "0031158109", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "611", "@last": "614"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Bookman", "ce:indexed-name": "Bookman M.A."}, {"@seq": "2", "ce:initials": "D.D.", "@_fa": "true", "ce:surname": "Kloth", "ce:indexed-name": "Kloth D.D."}, {"@seq": "3", "ce:initials": "P.E.", "@_fa": "true", "ce:surname": "Kover", "ce:indexed-name": "Kover P.E."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Smolinski", "ce:indexed-name": "Smolinski S."}, {"@seq": "5", "ce:initials": "R.F.", "@_fa": "true", "ce:surname": "Ozols", "ce:indexed-name": "Ozols R.F."}]}, "ref-sourcetitle": "Ann Oncol"}}, {"ref-fulltext": "O'Cathail SM, Shaboodien R, Mahmoud S et al. Intravenous versus oral dexamethasone premedication in preventing Paclitaxel infusion hypersensitivity reactions in gynecological malignancies. Int J Gynecol Cancer 2013; 23: 1318\u201325.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Intravenous versus oral dexamethasone premedication in preventing Paclitaxel infusion hypersensitivity reactions in gynecological malignancies"}, "refd-itemidlist": {"itemid": {"$": "84884519778", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "1318", "@last": "1325"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "O'Cathail", "ce:indexed-name": "O'Cathail S.M."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Shaboodien", "ce:indexed-name": "Shaboodien R."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Mahmoud", "ce:indexed-name": "Mahmoud S."}], "et-al": null}, "ref-sourcetitle": "Int J Gynecol Cancer"}}, {"ref-fulltext": "Gennari A, Salvadori B, Tognoni A, Conte PF. Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel. Ann Oncol 1996; 7: 978\u20139.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "1996"}, "ref-title": {"ref-titletext": "Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel"}, "refd-itemidlist": {"itemid": {"$": "0030480108", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "978", "@last": "979"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Gennari", "ce:indexed-name": "Gennari A."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Salvadori", "ce:indexed-name": "Salvadori B."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Tognoni", "ce:indexed-name": "Tognoni A."}, {"@seq": "4", "ce:initials": "P.F.", "@_fa": "true", "ce:surname": "Conte", "ce:indexed-name": "Conte P.F."}]}, "ref-sourcetitle": "Ann Oncol"}}, {"ref-fulltext": "Micha JP, Rettenmaier MA, Dillman R, Fraser P, Birk C, Brown JV. Single-dose dexamethasone paclitaxel premedication. Gynecol Oncol 1998; 69: 122\u20134.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Single-dose dexamethasone paclitaxel premedication"}, "refd-itemidlist": {"itemid": {"$": "0032078097", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "69"}, "pagerange": {"@first": "122", "@last": "124"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Micha", "ce:indexed-name": "Micha J.P."}, {"@seq": "2", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Rettenmaier", "ce:indexed-name": "Rettenmaier M.A."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Dillman", "ce:indexed-name": "Dillman R."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Fraser", "ce:indexed-name": "Fraser P."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Birk", "ce:indexed-name": "Birk C."}, {"@seq": "6", "ce:initials": "J.V.", "@_fa": "true", "ce:surname": "Brown", "ce:indexed-name": "Brown J.V."}]}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "Markman M, Kennedy A, Webster K, Peterson G, Kulp B, Belinson J. An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions. J Cancer Res Clin Oncol 1999; 125: 427\u20139.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions"}, "refd-itemidlist": {"itemid": {"$": "0032997728", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "125"}, "pagerange": {"@first": "427", "@last": "429"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Markman", "ce:indexed-name": "Markman M."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Kennedy", "ce:indexed-name": "Kennedy A."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Webster", "ce:indexed-name": "Webster K."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Peterson", "ce:indexed-name": "Peterson G."}, {"@seq": "5", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Kulp", "ce:indexed-name": "Kulp B."}, {"@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Belinson", "ce:indexed-name": "Belinson J."}]}, "ref-sourcetitle": "J Cancer Res Clin Oncol"}}, {"ref-fulltext": "Kwon JS, Elit L, Finn M et al. A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel. Gynecol Oncol 2002; 84: 420\u20135.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel"}, "refd-itemidlist": {"itemid": {"$": "0036200913", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "84"}, "pagerange": {"@first": "420", "@last": "425"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Kwon", "ce:indexed-name": "Kwon J.S."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Elit", "ce:indexed-name": "Elit L."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Finn", "ce:indexed-name": "Finn M."}], "et-al": null}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "Tsavaris N, Kosmas C, Vadiaka M. A simplified premedication schedule for 1-hour paclitaxel administration. J Support Oncol 2005; 3: 77\u201381.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "A simplified premedication schedule for 1-hour paclitaxel administration"}, "refd-itemidlist": {"itemid": {"$": "15544387622", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "3"}, "pagerange": {"@first": "77", "@last": "81"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Tsavaris", "ce:indexed-name": "Tsavaris N."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Kosmas", "ce:indexed-name": "Kosmas C."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Vadiaka", "ce:indexed-name": "Vadiaka M."}]}, "ref-sourcetitle": "J Support Oncol"}}, {"ref-fulltext": "Kosmas C, Tsavaris N. A simplified premedication protocol for one-hour paclitaxel infusion in various combinations. Med Sci Monit 2006; 12: CR462\u20136.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "A simplified premedication protocol for one-hour paclitaxel infusion in various combinations"}, "refd-itemidlist": {"itemid": {"$": "33750944054", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "CR462", "@last": "CR466"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Kosmas", "ce:indexed-name": "Kosmas C."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Tsavaris", "ce:indexed-name": "Tsavaris N."}]}, "ref-sourcetitle": "Med Sci Monit"}}, {"ref-fulltext": "Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8: 18.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials"}, "refd-itemidlist": {"itemid": {"$": "77952274419", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "18"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.F.", "@_fa": "true", "ce:surname": "Schulz", "ce:indexed-name": "Schulz K.F."}, {"@seq": "2", "ce:initials": "D.G.", "@_fa": "true", "ce:surname": "Altman", "ce:indexed-name": "Altman D.G."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Moher", "ce:indexed-name": "Moher D."}]}, "ref-sourcetitle": "BMC Med"}}, {"ref-fulltext": "Common Terminology Criteria for Adverse Events v.4.03 (CTCAE) 2010 August 6, 2010.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "refd-itemidlist": {"itemid": {"$": "70350238222", "@idtype": "SGR"}}, "ref-text": "August 6, 2010", "ref-sourcetitle": "Common Terminology Criteria for Adverse Events v.4.03 (CTCAE)"}}, {"ref-fulltext": "Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol 2001; 33: 289\u201394.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Side effects of corticosteroid therapy"}, "refd-itemidlist": {"itemid": {"$": "0034820299", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "33"}, "pagerange": {"@first": "289", "@last": "294"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.L.", "@_fa": "true", "ce:surname": "Buchman", "ce:indexed-name": "Buchman A.L."}]}, "ref-sourcetitle": "J Clin Gastroenterol"}}, {"ref-fulltext": "Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA et al. Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol 2001; 19: 1809\u201317.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Reliability and validity of the functional assessment of cancer therapy-ovarian"}, "refd-itemidlist": {"itemid": {"$": "0035868845", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "19"}, "pagerange": {"@first": "1809", "@last": "1817"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Basen-Engquist", "ce:indexed-name": "Basen-Engquist K."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Bodurka-Bevers", "ce:indexed-name": "Bodurka-Bevers D."}, {"@seq": "3", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Fitzgerald", "ce:indexed-name": "Fitzgerald M.A."}], "et-al": null}, "ref-sourcetitle": "J Clin Oncol"}}, {"ref-fulltext": "DeMets DL, Lan KK. Interim analysis: The alpha spending function approach. Stat Med 1994; 13: 1341\u201352; discussion 53-6.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "1994"}, "ref-title": {"ref-titletext": "Interim analysis: The alpha spending function approach"}, "refd-itemidlist": {"itemid": {"$": "0027934302", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "1341", "@last": "1352"}}, "ref-text": "discussion 53-6", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.L.", "@_fa": "true", "ce:surname": "DeMets", "ce:indexed-name": "DeMets D.L."}, {"@seq": "2", "ce:initials": "K.K.", "@_fa": "true", "ce:surname": "Lan", "ce:indexed-name": "Lan K.K."}]}, "ref-sourcetitle": "Stat Med"}}, {"ref-fulltext": "Rosenberg P, Andersson H, Boman K et al. Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum. Acta Oncol 2002; 41: 418\u201324.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum"}, "refd-itemidlist": {"itemid": {"$": "0036407202", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "41"}, "pagerange": {"@first": "418", "@last": "424"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Rosenberg", "ce:indexed-name": "Rosenberg P."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Andersson", "ce:indexed-name": "Andersson H."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Boman", "ce:indexed-name": "Boman K."}], "et-al": null}, "ref-sourcetitle": "Acta Oncol"}}, {"ref-fulltext": "Hochhaus G, Barth J, al-Fayoumi S et al. Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP). J Clin Pharmacol 2001; 41: 425\u201334.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP)"}, "refd-itemidlist": {"itemid": {"$": "0035070159", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "41"}, "pagerange": {"@first": "425", "@last": "434"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Hochhaus", "ce:indexed-name": "Hochhaus G."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Barth", "ce:indexed-name": "Barth J."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "al-Fayoumi", "ce:indexed-name": "al-Fayoumi S."}], "et-al": null}, "ref-sourcetitle": "J Clin Pharmacol"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Pathum Thani", "@id": "60023366", "affilname": "Rangsit University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60005255", "affilname": "Rajavithi Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84983311786", "dc:description": "Aim: To compare the efficacies and side effects of intravenous and oral dexamethasone (IV-D and PO-D) for paclitaxel-associated hypersensitivity reaction (P-HSR) prophylaxis in patients with primary ovarian, fallopian tube and peritoneal carcinomas (POC/PFTC/PPC) receiving a first cycle of paclitaxel plus carboplatin (TC). Methods: In this double-blind randomized controlled trial, patients with POC/PFTC/PPC receiving a first cycle of TC were randomly allocated in a 1:1 ratio to either the IV-D or PO-D groups. Those were followed at 28 days. Primary outcomes were incidence of overall and severe P-HSRs. Secondary outcomes included incidence of dexamethasone-related side effects, other chemotherapy-related adverse events (AEs), and quality-of-life (QoL). Results: A total of 288 patients were enrolled from February to July 2015, of whom 281 were eligible for analysis, including 140 allocated to IV-D and 141 to PO-D. There was no significant difference in P-HSR rate between the IV-D and PO-D groups (17.9% vs. 19.1%, P = 0.780). Severe P-HSR occurred in one women in the IV-D group (0.7% vs. 0%, P = 0.498). There were no significant differences in other chemotherapy-related AEs and QoL scores. However, women in the PO-D had more side effects from short-term corticosteroid use than those in the IV-D group, especially acne (10.6% vs. 2.1%, P = 0.004). Conclusions: IV-D and PO-D have similar efficacies for preventing P-HSR. However, short-term IV-D may be associated with fewer side effects than PO-D. IV-D is thus suggested for P-HSR prophylaxis in patients with POC/PFTC/PPC receiving a first cycle of TC.", "pubmed-id": "27098551", "prism:coverDate": "2016-09-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84983311786", "dc:creator": {"author": [{"ce:given-name": "Marut", "preferred-name": {"ce:given-name": "Marut", "ce:initials": "M.", "ce:surname": "Yanaranop", "ce:indexed-name": "Yanaranop M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": [{"@id": "60005255", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255"}, {"@id": "60023366", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366"}], "ce:surname": "Yanaranop", "@auid": "6504113309", "author-url": "https://api.elsevier.com/content/author/author_id/6504113309", "ce:indexed-name": "Yanaranop M."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84983311786"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84983311786&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84983311786&origin=inward"}], "source-id": "4000148021", "citedby-count": "14", "prism:volume": "12", "subtype": "ar", "dc:title": "Intravenous versus oral dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in patients with primary ovarian, fallopian tube and peritoneal cancer: A double-blind randomized controlled trial", "openaccess": "0", "prism:issn": "17437563 17437555", "publishercopyright": "\u00a9 2016 John Wiley & Sons Australia, Ltd", "prism:issueIdentifier": "3", "subtypeDescription": "Article", "prism:publicationName": "Asia-Pacific Journal of Clinical Oncology", "prism:pageRange": "289-299", "prism:endingPage": "299", "openaccessFlag": "false", "prism:doi": "10.1111/ajco.12495", "prism:startingPage": "289", "dc:identifier": "SCOPUS_ID:84983311786", "dc:publisher": "Blackwell Publishing Ltdcustomerservices@oxonblackwellpublishing.com"}, "idxterms": null, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "dexamethasone"}, {"@_fa": "true", "$": "hypersensitivity reaction"}, {"@_fa": "true", "$": "ovarian cancer"}, {"@_fa": "true", "$": "paclitaxel"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Oncology", "@code": "2730", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Marut", "preferred-name": {"ce:given-name": "Marut", "ce:initials": "M.", "ce:surname": "Yanaranop", "ce:indexed-name": "Yanaranop M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": [{"@id": "60005255", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255"}, {"@id": "60023366", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366"}], "ce:surname": "Yanaranop", "@auid": "6504113309", "author-url": "https://api.elsevier.com/content/author/author_id/6504113309", "ce:indexed-name": "Yanaranop M."}, {"ce:given-name": "Surasith", "preferred-name": {"ce:given-name": "Surasith", "ce:initials": "S.", "ce:surname": "Chaithongwongwatthana", "ce:indexed-name": "Chaithongwongwatthana S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Chaithongwongwatthana", "@auid": "6602320037", "author-url": "https://api.elsevier.com/content/author/author_id/6602320037", "ce:indexed-name": "Chaithongwongwatthana S."}]}}}